Nuevolution reels in €11 million for discovery work; Pfizer ditches online trial recruitment for study;

@FierceBiotech: The Fierce team has landed in Boston. Check out our dedicated BIO2012 page. Special Coverage | Follow @FierceBiotech

@JohnCFierce: Thanks to Bernard Munos, Jim Burns, Jason Gardner, Jill Milne, Mene Pangalos and 300+ of my closest friends for a great conversation this a.m. | Follow @JohnCFierce

@RyanMFierce: FDA has shot down Pfizer's bid for approval of TTR-FAP rare disease drug. News | Follow @RyanMFierce

> Danish drug discovery group Nuevolution has brought in €11 million in new financing from Industrifonden and repeat backers Sunstone Capital, SEB Venture Capital and SEB Utvecklingsstiftelse. Release

> The FDA and EMA granted orphan drug status to bluebird bio's experimental gene therapy for adrenoleukodystrophy, which is also known as Lorenzo's Oil disease. Release

> Pharmalot's Ed Silverman reports that Pfizer ($PFE) has pulled the plug on an effort to recruit patients for clinical trials with social media and computer technologies. News

> XTL Biopharmaceuticals revealed plans to scoop up Kitov Pharmaceuticals for shares and cash milestones that could reach $48 million. Item

> British biotech Heptares Therapeutics has extended its collaboration with the UK Medical Research Council to study the structure of transmembrane proteins. Release

Pharma News

@FiercePharma: Will Human Genome's bid deadline backfire? Or will $GSK be thwarted by some secretive white knight? Report | Follow @FiercePharma

> With Brennan gone, AstraZeneca megamerger talk can resume. Article

> No overtime for pharma reps, Supreme Court says. Story

> Merck Serono's final answer: Geneva HQ will close. News

Medical Devices News

 @FierceMedDev: We have extended the nomination deadline for the 15 fiercest medical device developers to July 13. Spread the word. Survey | Follow @FierceMedDev

 @MarkHFierce: Our coverage of the 2012 BIO International Convention continues. Roundup | Follow @MarkHFierce

> Medical device/Dx VC funding has gotten 'a little' better. Report

> China Medical's investors petition for liquidation. News

> At BIO, experts rethink how to make companion diagnostics viable. Article

> A declining rupee could spell trouble for India's medical equipment imports. Item

Biotech Research News

> In life sciences R&D, China is reaching for the stars. Editor's corner

> Pluristem's placental stem cells spur bone marrow growth. Story

> Genetic markers uncovered for rare children's brain tumor. Report

> Breakthrough: Human Microbiome Project maps healthy body microbes. More

Pharma Manufacturing News

> Amneal Pharmaceuticals quadruples manufacturing. Item

> Just about everyone agrees: drug shortages are a complex puzzle. Story

> Canadian Internet pharmacy leader faces federal charges. Article

And Finally… A study suggests that getting rays could reduce a person's risk of getting pancreatic cancer. Article

Suggested Articles

Moderna’s shares shrunk by nearly 5% before the long holiday weekend Thursday after a report out by Stat said the biotech was delaying its trial.

Keep your post-pandemic trials on track: learn how the right clinical supply chain partner can help sponsors avoid trial disruption. Read now>>

Helsinn Group and MEI Pharma penned a near $500 million biobucks pact for experimental blood cancer drug pracinostat back in 2016.